Loading...
Loading...
All product recalls affecting Wyoming.
Includes nationwide recalls (tagged “Nationwide”) and recalls with Wyoming in the distribution area.
Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate
Event Catalog information does not save when copied and transferred from one unit to another.
Hyundai Motor America (Hyundai) is recalling certain 2024 IONIQ 6 vehicles. The differential gear bolts in the gear drive unit may not be tightened properly, which can result in a loss of drive power or cause the differential to lock up.
REV Recreation Group (REV) is recalling certain 2022-2024 Fleetwood Discovery and Holiday Rambler Endeavor motorhomes, equipped with Remco 50-54 Rebel 4.0 GPM water pumps. The water pump harness was designed with inadequate fuse protection.
Tesla, Inc. (Tesla) is recalling one 2024 Model 3 vehicle. The driver seat side air bag module was assembled without a deflector that directs gas flow during deployment.
Goodyear Tire & Rubber Company (Goodyear) is recalling certain G622 RSD, size 225/70R19.5 tires. The tires contain a tire identification number (TIN) that is missing the 4-digit week and year code mark. As such, these tires fail to comply with the requirements of Federal Motor Vehicle Safety Standard number 574, "Tire Identification & Recordkeeping."
Forest River, Inc. (Forest River) is recalling certain 2024 Coachmen Catalina BCAT154RDX and Forest River Aurora BART15RDX travel trailers. The panel that isolates the cooktop from the furnace was not properly sealed during manufacturing, which could result in an inverted cooktop flame.
Hyundai Motor America (Hyundai) is recalling certain 2022-2023 Genesis GV70, GV80, G80, and G90 vehicles. The fuel pump may fail, which can result in a loss of drive power.
REV Ambulance Group Orlando, Inc. (REV) is recalling certain 2019-2024 Type I, Type III, and Type IX vehicles equipped with certain Weldon Vmux HC1.7 Input/Output multiplex nodes. In the event of a short circuit or wiring failure, the firmware in the node may fail to shut off the output pin, resulting in overloaded electrical circuits.
Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Out of specification for assay
Nimbus II Plus, Infusion Pump Systems, manufactured by InfuTronix, are being removed the from the market due to multiple potential failure modes, including battery failure, upstream occlusion, system errors, drug product leakage, high or low flow rate, or damaged pump housing.
Exactech is recalling all affected UHMWPE (ultra-high molecular weight polyethylene) knee patella components packaged in out of specification vacuum bags.
Stryker Neurovascular has observed an increased frequency of PTFE coating damage occurring on the Synchro Guidewires that may be caused by the practice of backloading the guidewire through the optional introducer accessory. This issue is limited to certain lots of the Synchro Guidewire that contain an older version of the introducer accessory. Due to variation in the manufacturing process of the supplier of the introducer accessory, certain lots of introducers have sharper than intended edges that can peel off the PTFE coating when physicians use a technique known as backloading. Users with impacted product in their inventory are cautioned not to use this backloading technique.
Stryker Neurovascular has observed an increased frequency of PTFE coating damage occurring on the Synchro Guidewires that may be caused by the practice of backloading the guidewire through the optional introducer accessory. This issue is limited to certain lots of the Synchro Guidewire that contain an older version of the introducer accessory. Due to variation in the manufacturing process of the supplier of the introducer accessory, certain lots of introducers have sharper than intended edges that can peel off the PTFE coating when physicians use a technique known as backloading. Users with impacted product in their inventory are cautioned not to use this backloading technique.
Beckman Coulter is recalling their DxI 9000 Access Immunoassay Analyzers, an in vitro diagnostic device used for the quantitative, semi-quantitative, or qualitative determination of various analyte concentrations found in human body fluids, by correction. The reason for the recall is: Beckman Coulter has determined that the DxI 9000 Access Immunoassay analyzer accepts calibrator values scanned from multiple calibrator cards when an operator configures a new calibrator lot. The analyzer accepts the calibrator lot values from any scanned calibrator card, regardless of the assay test code or calibrator material lot number. The software is not validating the integrity of each calibrator barcode scanned to ensure they are all from the same calibrator card. This includes all software versions and all DxI 9000 instruments that are currently in the field. This issue does not impact calibrator material with 2D calibrator card barcodes. This may cause a failed calibration curve. The health risk to patients is dependent upon the analytes that could be impacted by the error, to include receiving delayed or erroneous results. The issue was identified by Beckman Coulter while conducting a field action on DxI 9000 Access Immunoassay Analyzers.
Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) may experience routine system check during IPG charging, which may cause device reset. The device reset could lead transient loss of stimulation; patients may experience undesired sensations, transient worsening of movement disorder symptoms, which may lead patient to request surgical intervention for replacement or revision.